Onderneming InspireMD Inc Nyse
Aandelen
US45779A8615
Medische apparatuur, benodigdheden & distributie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
CGuard Embolic Prevention System
100,0
%
| 5 | 99,1 % | 6 | 100,0 % | +21,12% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Other
54,4
%
| 3 | 64,5 % | 3 | 54,4 % | +1,23% |
Italy
19,3
%
| 1 | 18,8 % | 1 | 19,3 % | +23,20% |
Germany
14,4
%
| 1 | 16,7 % | 1 | 14,4 % | +3,46% |
Russia
11,9
%
| - | - | 1 | 11,9 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01-01-20 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 31-03-11 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
Andrea Tommasoli
COO | Chief Operating Officer | 52 | 03-11-20 |
Patrick Verta
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Cheryl Tal
LAW | General Counsel | - | 03-10-23 |
Tamar Nativ
PRN | Corporate Officer/Principal | - | - |
Shane Gleason
PRN | Corporate Officer/Principal | 50 | - |
Amir Kohen
HRO | Human Resources Officer | 63 | 01-05-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 13-10-20 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01-01-20 |
Thomas Kester
BRD | Director/Board Member | 77 | 06-09-16 |
Michael Berman
BRD | Director/Board Member | 66 | 07-02-13 |
Paul Stuka
CHM | Chairman | 69 | 08-08-11 |
Kathryn Arnold
BRD | Director/Board Member | 51 | 10-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 718 | 0 | 0 | 81,51 % |
Aandeel B | 1 | 23 401 435 | 19 073 472 ( 81,51 %) | 0 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,98% | 182 mld. | |
+2,84% | 112 mld. | |
-2,68% | 68,58 mld. | |
+4,53% | 51,58 mld. | |
+8,00% | 44,24 mld. | |
+9,65% | 43,65 mld. | |
+25,30% | 32,46 mld. | |
-0,17% | 25,61 mld. | |
+21,57% | 25,99 mld. |